Is Gain Therapeutics, Inc. overvalued?

Gain Therapeutics, Inc. (GANX) — key valuation metrics and fundamentals.

No verdict

Price

$2.12

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$90.4M

Dividend yield

0.0%

Return on equity

-201.4%

Sector

Healthcare

Fair value compares GANX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks